Stanford study confirms this drug can treat sleep loss, insomnia

Scientists from Stanford University found drug daridorexant (50 mg) improves both nighttime symptoms and daytime functioning in people with insomnia disorder.

The research is published in The Lancet Neurology and was conducted by Emmanuel Mignot et al.

Daridorexant, sold under the brand name Quviviq, is a medication used for the treatment of insomnia.

In the study, the team assigned 930 adults with insomnia disorder to receive either daridorexant (50 mg, 25 mg) or placebo in study 1 and 924 adults to receive either daridorexant (25 mg, 10 mg) or placebo in study 2 every evening for three months.